High Levels of Tumor miR-187-3p—A Potential Tumor-Suppressor microRNA—Are Correlated with Poor Prognosis in Colorectal Cancer
Authors:
- Lui NgLui Ng
- Timothy Ming-Hun WanTWTimothy Ming-Hun Wan
- Deepak Narayanan IyerDeepak Narayanan Iyer
- Zheng HuangZHZheng Huang
- Ryan Wai-Yan SinRSRyan Wai-Yan Sin
- Abraham Tak-Ka ManAMAbraham Tak-Ka Man
- Xue LiXLXue Li
- Dominic Chi-Chung FooDFDominic Chi-Chung Foo
- Oswens Siu-Hung LoOLOswens Siu-Hung Lo
- Wai-Lun LawWLWai-Lun Law
Open Access
Abstract
Background: The microRNA miR-187-3p plays antitumor roles in a variety of cancers. We and others have previously identified miR-187-3p as a potential tumor suppressor in colorectal cancer (CRC), but there are also reports revealing that high miR-187-3p levels are associated with poor prognosis among CRC patients. This study further investigated the clinicopathological significance of miR-187-3p in CRC. Methods: MiR-187-3p levels in paired polyp/CRC/normal specimens or primary CRC/liver metastasis specimens were determined by qPCR, and correlated with the patient’s clinicopathological and postoperative survival data. The clinical findings were validated using our validation cohort and data obtained from the TCGA or GEO databases. The functional effects of miR-187-3p were investigated through its overexpression in CRC cell lines. Results: MiR-187-3p was significantly repressed in colorectal polyps and CRC when compared to adjacent normal tissue. Overexpression of miR-187-3p in CRC cell lines impaired colony formation, cell migration, and invasion, and induced chemosensitivity. Clinical analysis revealed that despite miR-187-3p being repressed in CRC, high tumor miR-187-3p levels were positively correlated with tumor stage and disease recurrence. Further analysis showed that miR-187-3p levels were lower in metastatic specimens when compared to paired primary CRC, suggesting that high tumor miR-187-3p levels resulted from the dissemination of metastatic tumor cells. Tumor miR-187-3p levels were positively correlated with peripheral inflammation-related blood markers. Finally, SPRY1 was identified as a novel target gene of miR-187-3p, and was involved in miR-187-3p-impaired CRC metastasis. Conclusions: This study demonstrated that in spite of its repression and role as a tumor suppressor in CRC, high levels of miR-187-3p in tumors were correlated with poor prognosis and higher levels of peripheral inflammation-related blood markers.Keywords
Funding Information
- Health and Medical Research Fund of the Research Fund Secretariat, Food and Health Bureau (06173406)
This publication has 39 references indexed in Scilit:
- Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatinWorld Journal of Gastroenterology, 2014
- MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3Biochemical and Biophysical Research Communications, 2013
- miR-187 Is an Independent Prognostic Factor in Breast Cancer and Confers Increased Invasive PotentialIn VitroClinical Cancer Research, 2012
- Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancerColorectal Disease, 2012
- Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2Oncogene, 2011
- Contribution of platelets to tumour metastasisNature Reviews Cancer, 2011
- Platelet adhesion and fusion to endothelial cell facilitate the metastasis of tumor cell in hypoxia-reoxygenation conditionClinical & Experimental Metastasis, 2010
- Platelet Granule Secretion Continuously Prevents Intratumor HemorrhageCancer Research, 2008
- Colorectal cancerThe Lancet, 2005
- Genetic predisposition to colorectal cancerNature Reviews Cancer, 2004